Ray Therapeutics vs TIXiMED
Ray Therapeutics vs TIXiMED, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Ray Therapeutics is on 53/100 and TIXiMED on 49/100.
Where each one leads
Ray Therapeutics
- our overall score: 53/100 against 49/100
- domain rating: 29/100 against 4/100
- funding raised: $243M against $4.8M
TIXiMED
- agent readiness: 55/100 against 21/100
At a glance
| Measure | Ray Therapeutics | TIXiMED |
|---|---|---|
| What it is | Pioneering vision restoration therapies for severe retinal degenerations. | Clinical-stage pharmaceutical company developing innovative oral therapies for diabetes and metabolic disorders. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Medical Devices | Biotechnology, Pharmaceuticals, HealthTech, Medical Devices |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2021 | 2021 |
| Headquarters | Berkeley, USA | Birmingham, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Ray Therapeutics | TIXiMED |
|---|---|---|
| Employees | Not published | 5 |
| Total funding | $243M | $4.8M |
| Latest round | Series B | Seed |
| Valuation | Not published | $1.1B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Ray Therapeutics | TIXiMED |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 49/100 |
| Traction | 40/100 | 41/100 |
| Team | 50/100 | 60/100 |
| Search visibility | 14/100 | 5/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | D (55/100) |
| Domain ratingLink authority, 0-100 | 29/100 | 4/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Ray Therapeutics | TIXiMED |
|---|---|---|
| Hosting | Not detected | Google Cloud |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Not detected |
Ray Therapeutics vs TIXiMED: common questions
Which is better, Ray Therapeutics or TIXiMED?
On our 0-100 score Ray Therapeutics rates higher (53/100 against 49/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Ray Therapeutics and TIXiMED compare on the numbers?
Ray Therapeutics leads on our overall score (53/100 against 49/100), domain rating (29/100 against 4/100), funding raised ($243M against $4.8M). TIXiMED leads on agent readiness (55/100 against 21/100).
Read the full Ray Therapeutics review and pricing or the TIXiMED review and pricing. You can also browse other Ray Therapeutics alternatives we track.